Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Haleon Plc on September 3, 2024, for the month of September 2024. Haleon is a global leader in consumer health with a portfolio spanning Oral Health, Pain Relief, Respiratory Health, Digestive Health, and Vitamins, Minerals, and Supplements (VMS). The filing serves as a notification of total voting rights and capital structure.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on capital structure and voting rights.
Material Changes
As of August 31, 2024, the total number of issued ordinary shares with voting rights is 9,123,638,944. Each share has a nominal value of £0.01. There are no ordinary shares held in Treasury. This figure serves as the denominator for shareholders calculating notification obligations under the Disclosure and Transparency Rules of the Financial Conduct Authority.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is a statutory disclosure regarding share capital.
Key Facts for Investor Verification
- Total issued voting shares as of August 31, 2024: 9,123,638,944.
- Share nominal value: £0.01 per ordinary share.
- Treasury shares: None.
- Notifiable interests should be directed to company.secretary@haleon.com.
- The Company Secretary responsible for the release is Amanda Mellor.